A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500540-38-00

Acronym

CQEQ278A12101

Enrollment

Registered

2022-12-06

Start date

2023-06-27

Completion date

2025-01-22

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer Oesophageal squamous cell carcinoma Renal cell carcinoma Squamous cell carcinoma of head and neck

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026